• Investors
    • Press Releases
    • Events and Presentations
    • Scientific & Medical Presentations
    • SEC Filings
    • Corporate Governance
    • Stock Information
    • Investor FAQs
    • Email Alerts
  • Patients
  • About
    • Board of Directors
    • Global Scientific Advisory Board
    • Management Team
  • Retinal Disease
  • Technology
  • Pipeline
    • Clinical Trials
    • OTX-TKI
    • OTX – TIC
  • Products
  • Careers
    • Benefits
    • Open Positions
  • Contact Us
  • Investors
    • Press Releases
    • Events and Presentations
    • Scientific & Medical Presentations
    • SEC Filings
    • Corporate Governance
    • Stock Information
    • Investor FAQs
    • Email Alerts
  • Patients
  • About
    • Board of Directors
    • Global Scientific Advisory Board
    • Management Team
  • Retinal Disease
  • Technology
  • Pipeline
    • Clinical Trials
    • OTX-TKI
    • OTX – TIC
  • Products
  • Careers
    • Benefits
    • Open Positions
  • Contact Us
  • Investors
    • Press Releases
    • Events and Presentations
    • Scientific & Medical Presentations
    • SEC Filings
    • Corporate Governance
    • Stock Information
    • Investor FAQs
    • Email Alerts
  • Patients
  • Careers
    • Benefits
    • Open Positions
  • Contact Us
  • Investors
    • Press Releases
    • Events and Presentations
    • Scientific & Medical Presentations
    • SEC Filings
    • Corporate Governance
    • Stock Information
    • Investor FAQs
    • Email Alerts
  • Patients
  • Careers
    • Benefits
    • Open Positions
  • Contact Us
  • About
    • Management Team
    • Board of Directors
    • Global Scientific Advisory Board
  • Retinal Disease
  • Technology
  • Pipeline
    • Clinical Trials
    • OTX-TKI
    • OTX-TIC
  • Products
  • About
    • Management Team
    • Board of Directors
    • Global Scientific Advisory Board
  • Retinal Disease
  • Technology
  • Pipeline
    • Clinical Trials
    • OTX-TKI
    • OTX-TIC
  • Products

Category: Uncategorized

ABOUT

  • Company Overview
  • Management Team
  • Board of Directors
  • Global Scientific Advisory Board

INVESTORS

  • Press Releases
  • Events & Presentations
  • Scientific & Medical Presentations
  • SEC Filings
  • Corporate Governance
  • Stock Information
  • Investors FAQs
  • Email Alerts

RETINAL DISEASE

TECHNOLOGY

PIPELINE

PRODUCTS

©2025 Ocular Therapeutix, Inc. All rights reserved. DEXTENZA is a registered trademark 
and ELUTYX and AXPAXLI are trademarks of Ocular Therapeutix, Inc. 

  • Terms of Use
  • Privacy Policy
  • Compliance
  • Expanded Access Program
  • Terms of Use
  • Privacy Policy
  • Compliance
  • Expanded Access Program